Weekly and 90-Minute Biological Variations in Cardiac Troponin T and Cardiac Troponin I in Hemodialysis Patients and Healthy Controls

被引:76
作者
Aakre, Kristin M. [1 ,2 ]
Roraas, Thomas [3 ]
Petersen, Per Hyltoft [3 ]
Svarstad, Einar [4 ,5 ]
Sellevoll, Hilde [5 ]
Skadberg, Oyvind [6 ]
Saele, Kristin [5 ]
Sandberg, Sverre [1 ,3 ]
机构
[1] Haukeland Hosp, Lab Clin Biochem, N-5021 Bergen, Norway
[2] Norwegian Clin Chem EQA Program, Bergen, Norway
[3] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Norwegian Qual Improvement Primary Care Labs NOKL, Bergen, Norway
[4] Univ Bergen, Dept Clin Med, Bergen, Norway
[5] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway
[6] Stavanger Univ Hosp, Lab Clin Biochem, Stavanger, Norway
关键词
ACUTE CORONARY SYNDROME; EARLY-DIAGNOSIS; MYOCARDIAL-INFARCTION; SERIAL CHANGES; VARIABILITY; ASSAY; PREDICTION; ABSOLUTE; DISEASE; VALUES;
D O I
10.1373/clinchem.2013.216978
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BACKGROUND: Myocardial infarction (MI) is diagnosed by the finding of a single cardiac troponin value above the 99th percentile and a significant time-dependent change in cardiac troponin concentration. The aim of this study was to determine the 90-min and weekly biological variations, the reference change value (RCV), and the index of individuality (II) of high-sensitivity cardiac troponin T (hs-cTnT) (Roche Diagnostics) and hs-cTnI (Abbott Diagnostics) in patients receiving hemodialysis (HD) and in healthy individuals. METHOD: Blood samples were collected from 19HD patients (on an HD-free day) and 20 healthy individuals at 90-min intervals over a 6-h period (between 08:30 and 14:30) and before the midweek HD treatment for 10 weeks. The within-person variation (CVi), between-person variation, RCV, and II were calculated. RESULTS: During the 6-h sampling period, the concentrations of hs-cTnT (both groups) and hs-cTnI (HD patients only) decreased on average by 0.8% to 1.7% per hour, respectively. These declining trends were included in the calculation of a 90-min asymmetric RCV: -8%/+5% in HD patients (hs-cTnT), -18%/+21% in HD patients (hs-cTnI), -27%/+29% in healthy individuals (hs-cTnT), and -39%/+64% in healthy individuals (hs-cTnI). The II was low in both groups for both assays. The weekly CVi values were approximately 8% (hs-cTnT) and 15% (hs-cTnI) in both groups. CONCLUSIONS: When using a cardiac troponin change of 20%-50% to diagnose an MI, the false-positive rate is likely to be lower for the hs-cTnT assay than for the hs-cTnI assay. The low II suggests that use of a diagnostic cutoff value can be omitted. (C) 2014 American Association for Clinical Chemistry
引用
收藏
页码:838 / 847
页数:10
相关论文
共 40 条
[1]   Early Dynamic Change in High-Sensitivity Cardiac Troponin T in the Investigation of Acute Myocardial Infarction [J].
Aldous, Sally J. ;
Richards, A. Mark ;
Cullen, Louise ;
Than, Martin P. .
CLINICAL CHEMISTRY, 2011, 57 (08) :1154-1160
[2]  
[Anonymous], 1994, PRINCIPLES ELECT INS
[3]  
[Anonymous], CLIN CHEM
[4]  
[Anonymous], 2011, CLIN CHEM
[5]   Determination of 19 Cardiac Troponin I and T Assay 99th Percentile Values from a Common Presumably Healthy Population [J].
Apple, Fred S. ;
Ler, Ranka ;
Murakami, MaryAnn M. .
CLINICAL CHEMISTRY, 2012, 58 (11) :1574-1581
[6]   Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays [J].
Apple, Fred S. ;
Collinson, Paul O. .
CLINICAL CHEMISTRY, 2012, 58 (01) :54-61
[7]   Role of Monitoring Changes in Sensitive Cardiac Troponin I Assay Results for Early Diagnosis of Myocardial Infarction and Prediction of Risk of Adverse Events [J].
Apple, Fred S. ;
Pearce, Lesly A. ;
Smith, Stephen W. ;
Kaczmarek, Jason M. ;
Murakami, MaryAnn M. .
CLINICAL CHEMISTRY, 2009, 55 (05) :930-937
[8]  
Biener Moritz, 2013, Int J Cardiol, V167, P1134, DOI 10.1016/j.ijcard.2012.09.122
[9]  
BURNETT RW, 1975, CLIN CHEM, V21, P1935
[10]   Within-subject biological variation of glucose and HbA1c in healthy persons and in type 1 diabetes patients [J].
Carlsen, Siri ;
Petersen, Per Hyltoft ;
Skeie, Svein ;
Skadberg, Oyvind ;
Sandberg, Sverre .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (09) :1501-1507